Equities

Bio-UV Group SA

Bio-UV Group SA

Actions
IndustrialsElectronic and Electrical Equipment
  • Price (EUR)1.95
  • Today's Change0.018 / 0.93%
  • Shares traded22.35k
  • 1 Year change-40.00%
  • Beta0.2687
Data delayed at least 15 minutes, as of Sep 24 2024 16:35 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Bio-Uv Group SAS is a France-based company, which operates as a manufacturer of ultraviolet light water treatment equipment. The Company designs, manufactures and markets systems and concepts of disinfection by ultraviolet light (UV-C) adapted to a number of applications, which enable automatic chlorine-free treatment for residential and collective swimming pools and spas. Bio-Uv Group SAS divides its range of products into two main segments: Individual, which includes residential pools & spas, fish ponds and aquariums and domestic drinking water for human consumption, and Professionals, which includes commercial pools and spas for professionals, water treatment, ballast water treatment, aquaculture, aquariums and fountains, among others.

  • Revenue in EUR (TTM)43.13m
  • Net income in EUR124.90k
  • Incorporated2010
  • Employees160.00
  • Location
    Bio-UV Group SA850 avenue Louis MedardLUNEL 34403FranceFRA
  • Phone+33 499133911
  • Fax+33 499133919
  • Websitehttps://www.bio-uv.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Lucibel SA9.04m73.00k5.62m52.0049.1312.148.410.62210.00460.00460.46490.01870.95451.0622.90173,750.000.7712-16.152.76-41.8664.3950.690.808-20.370.37821.910.90--10.492.24103.19---20.09--
Egide SA36.71m-3.12m5.85m280.00--0.8327--0.1594-0.2214-0.22142.740.43231.311.935.84131,121.40-11.12-7.25-20.49-12.5359.3658.27-8.50-6.780.8861-1.960.6483--8.442.9644.52---15.97--
Corep Lighting SA17.82m552.00k7.41m199.0011.792.727.620.41550.76310.763124.513.30------89,567.84--0.2237--0.392133.3622.453.100.14361.29--0.6211---2.095.49-216.61---11.28--
Upergy44.54m597.81k9.23m286.0015.180.62438.620.20720.12850.12859.573.121.412.765.49155,718.801.892.293.083.7625.8026.601.341.531.044.920.3354--1.430.6972-58.38--0.9769--
Made SA-100.00bn-100.00bn10.40m41.00------------------------------------------------4.74---17.67------
Enogia SA5.07m-2.46m12.17m51.00--1.52--2.40-0.4721-0.47210.80381.270.3059-1.861.2099,490.20-14.84---24.92--132.79---48.52--1.61-33.870.3339--53.94--43.26------
Balyo SA26.67m-9.76m17.01m144.00------0.6378-0.282-0.2820.7767-0.35120.82022.285.26185,175.70-30.03-25.71-147.03-69.5234.8130.96-36.61-36.490.6902-17.893.02--10.452.77-114.02---37.94--
Bio-UV Group SA43.13m124.90k19.99m160.00160.070.60926.060.46350.01210.01214.173.170.59291.618.61269,589.300.17171.150.23271.4935.6433.720.28961.870.66732.280.4674---15.8928.28-94.8321.95-0.0734--
MG International SA60.71m2.78m22.81m108.008.210.66986.430.37570.53810.538111.846.600.96251.802.68562,096.804.4012.027.2618.5032.6432.494.576.861.3836.720.067514.99-14.9910.80-40.6519.048.41--
Arcure SA18.20m1.80m33.99m53.0027.174.938.851.870.21570.21572.531.190.9661.804.93343,385.808.61-8.4912.45-12.8074.6972.818.91-11.672.042.790.5165--39.6219.573,153.05--18.17--
We. Connect SA264.09m9.55m57.78m167.005.701.065.430.21883.443.4495.1118.431.673.656.371,581,391.006.044.7111.7413.0911.2110.963.622.881.0919.440.317811.4611.2116.7021.2017.07--9.86
Forsee Power SA171.24m-27.96m60.96m713.00--1.03--0.356-0.4406-0.44062.630.82911.033.167.86240,165.50-16.75-25.72-23.07-36.2024.2824.41-16.33-33.191.43-6.030.5265--54.2449.2114.14--27.39--
Lacroix Group SA761.18m4.27m91.03m3.94k20.430.49623.080.11960.92290.9229157.6237.991.273.545.95193,242.70-0.4741---0.9082--29.80---0.3732--0.83042.790.4755--7.55---64.06------
Data as of Sep 24 2024. Currency figures normalised to Bio-UV Group SA's reporting currency: Euro EUR

Institutional shareholders

7.88%Per cent of shares held by top holders
HolderShares% Held
Lazard Fr�res Gestion SASas of 29 Sep 2023380.00k3.67%
OFI Invest Asset Management SAas of 29 Aug 2024150.00k1.45%
Talence Gestion SASas of 30 Aug 202486.60k0.84%
Mandarine Gestion SAas of 14 Sep 202381.42k0.79%
Consultinvest Asset Management SGR SpAas of 28 Jun 202460.63k0.59%
Cr�dit Mutuel Asset Management SAas of 30 Jun 202321.00k0.20%
FPM Frankfurt Performance Management AGas of 28 Jun 202420.00k0.19%
Centaur Fondf�rvaltning ABas of 31 Dec 202310.98k0.11%
Hogep Hoche Gestion Priv�e SAas of 31 Dec 20235.00k0.05%
CA Indosuez (Switzerland) SAas of 30 Jun 20240.000.00%
More ▼
Data from 31 Dec 2023 - 01 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.